Idebenone-Activating Autophagic Degradation of <i>α</i>-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson’s Disease: A Network Pharmacological Approach

<div>(a) Molecular structure of Idebenone. (b) Venn diagram of common targets of Idebenone for Parkinson’s disease.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Idebenone-Activating Autophagic Degradation of <i>α</i>-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson’s Disease: A Network Pharmacological Approach 

Figure 1 | Idebenone-Activating Autophagic Degradation of α-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson’s Disease: A Network Pharmacological Approach 